A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy
收藏DataCite Commons2025-02-03 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008291/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy of ustekinumab and CNTO 1959 in
reducing the signs and symptoms of disease in patients with active rheumatoid arthritis (RA)
despite concomitant methotrexate (MTX) therapy and to evaluate the safety of ustekinumab and
CNTO 1959 in this population.
提供机构：
Vivli
创建时间：
2022-07-20
